ReviewEuropean journal of endocrinology2022

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.

Margaret C S Boguszewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.